7189543
MilliporeSigma™ Supelco™ Astec™ CYCLOBOND™ I 2000 Chiral HPLC Column, 5 μm Particle Size
CYCLOBOND™ I 2000 is bonded with beta-cyclodextrin by a patented process to produce a stable matrix with the cyclodextrin arranged in such a way as to retain its most valuable property of forming inclusion complexes.
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Particle Size
5 μm
Stationary Phase
Cyclodextrin, Beta-
Matrix
Cyclodextrin, Beta- Phase/Silica Particle Platform
Technique
Chiral HPLC
Pore Size
100 Å
Product Line
Astec CYCLOBOND
Phase
Chiral
Related Products
Description
- CYCLOBOND™ I 2000 is bonded with beta-cyclodextrin by a patented process to produce a stable matrix with the cyclodextrin arranged in such a way as to retain its most valuable property of forming inclusion complexes
- This allows them to effect numerous chemical separations by selectively including into their cavities a wide variety of organic molecules
- Non-inclusion type separations are also possible with the polar organic mode for a wide variety of molecule types
- Bonded phase: Underivatized, native beta-cyclodextrin
Compare Similar Items
Show Difference
Particle Size: 5 μm
Stationary Phase: Cyclodextrin, Beta-
Matrix: Cyclodextrin, Beta- Phase/Silica Particle Platform
Technique: Chiral HPLC
Pore Size: 100 Å
Product Line: Astec CYCLOBOND
Phase: Chiral
Particle Size:
5 μm
Stationary Phase:
Cyclodextrin, Beta-
Matrix:
Cyclodextrin, Beta- Phase/Silica Particle Platform
Technique:
Chiral HPLC
Pore Size:
100 Å
Product Line:
Astec CYCLOBOND
Phase:
Chiral
Particle Size: 3 μm
Stationary Phase: 3-chloro-4 methylphenylcarbamate
Matrix: 3-chloro-4 methylphenylcarbamate Phase
Technique: Chiral HPLC
Pore Size: 1000 Å
Product Line: ChromegaChiral
Phase: Chiral
Particle Size:
3 μm
Stationary Phase:
3-chloro-4 methylphenylcarbamate
Matrix:
3-chloro-4 methylphenylcarbamate Phase
Technique:
Chiral HPLC
Pore Size:
1000 Å
Product Line:
ChromegaChiral
Phase:
Chiral
Particle Size: 2.7 μm
Stationary Phase: C18 (octadecyl)
Matrix: C18 (octadecyl) Phase/Fused-Core Particle Platform
Technique: Fused-Core HPLC
Pore Size: 1000 Å
Product Line: BIOshell
Phase: Reversed Phase
Particle Size:
2.7 μm
Stationary Phase:
C18 (octadecyl)
Matrix:
C18 (octadecyl) Phase/Fused-Core Particle Platform
Technique:
Fused-Core HPLC
Pore Size:
1000 Å
Product Line:
BIOshell
Phase:
Reversed Phase
Particle Size: __
Stationary Phase: __
Matrix: __
Technique: __
Pore Size: __
Product Line: SPB
Phase: __
Particle Size:
__
Stationary Phase:
__
Matrix:
__
Technique:
__
Pore Size:
__
Product Line:
SPB
Phase:
__